Authors:
BARDITCHCROVO P
NOE D
SKOWRON G
LEDERMAN M
KALAYJIAN RC
BORUM P
BUIER R
ROWE WB
GOLDBERG D
LIETMAN P
Citation: P. Barditchcrovo et al., A PHASE I II EVALUATION OF ORAL L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACIDIN ASYMPTOMATIC PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/, Journal of clinical pharmacology, 38(4), 1998, pp. 357-363
Authors:
DEEKS SG
BARDITCHCROVO P
LIETMAN PS
HWANG F
CUNDY KC
ROONEY JF
HELLMANN NS
SAFRIN S
KAHN JO
Citation: Sg. Deeks et al., SAFETY, PHARMACOKINETICS, AND ANTIRETROVIRAL ACTIVITY OF INTRAVENOUS 9-[2-(R)-(PHOSPHONOMETHOXY)PROPYL]ADENINE A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) THERAPY, IN HIV-INFECTED ADULTS, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2380-2384
Authors:
BARDITCHCROVO P
TRAPNELL CB
ETTE E
ZACUR H
FLEXNER C
Citation: P. Barditchcrovo et al., A PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF THE EFFECT OF RIFAMPIN AND RIFABUTIN ON COMBINATION ORAL-CONTRACEPTIVES, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 31-31
Authors:
CHUN TW
CARRUTH L
FINZI D
SHEN XF
DIGIUSEPPE JA
TAYLOR H
HERMANKOVA M
CHADWICK K
MARGOLICK J
QUINN TC
KUO YH
BROOKMEYER R
ZEIGER MA
BARDITCHCROVO P
SILICIANO RF
Citation: Tw. Chun et al., QUANTIFICATION OF LATENT TISSUE RESERVOIRS AND TOTAL-BODY VIRAL LOAD IN HIV-1 INFECTION, Nature, 387(6629), 1997, pp. 183-188
Authors:
BARDITCHCROVO P
TOOLE J
HENDRIX CW
CUNDY KC
EBELING D
JAFFE HS
LIETMAN PS
Citation: P. Barditchcrovo et al., ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITY, SAFETY, AND PHARMACOKINETICS OF ADEFOVIR DIPIVOXIL PIVALOYLOXYMETHYL)-PHOSPHONYLMETHOXYETHYL]ADENINE) IN HIV-INFECTED PATIENTS, The Journal of infectious diseases, 176(2), 1997, pp. 406-413
Authors:
MCPHERSON JL
NICHOLS JH
BARDITCHCROVO P
HAMZEH FM
Citation: Jl. Mcpherson et al., DETERMINATION OF THE SPERMICIDE NONOXYNOL-9 IN VAGINAL LAVAGE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 677(1), 1996, pp. 204-208
Authors:
WACHSMAN M
BARDITCHCROVO P
PETTY BG
TRAPNELL CB
BRUSILOW S
LIETMAN PS
Citation: M. Wachsman et al., SCREENING FOR BETA-OXIDATION ABNORMALITIES AS AN INDICATOR OF DRUG-INDUCED IMPAIRED MITOCHONDRIAL-FUNCTION IN PEOPLE RECEIVING ZIDOVUDINE (ZDV), Clinical pharmacology and therapeutics, 59(2), 1996, pp. 50-50
Authors:
BARDITCHCROVO P
WITTER F
HAMZEH F
MCPHERSON J
STRATTON P
ALEXANDER N
TRAPNELL CB
HOPKINS J
Citation: P. Barditchcrovo et al., QUANTITATION OF VAGINALLY ADMINISTERED NONOXYNOL-9 (N9) IN PREMENOPAUSAL WOMEN, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 97-97
Authors:
WACHSMAN M
BARDITCHCROVO P
LIETMAN PS
TRAPNELL CB
Citation: M. Wachsman et al., LACK OF BETA-OXIDATION DEFECTS IN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE SUBJECTS WITH AND WITHOUT CHRONIC ZIDOVUDINE EXPOSURE, Blood, 88(8), 1996, pp. 3243-3244
Citation: P. Barditchcrovo et al., APPARENT DEFICIENCY OF GLUTATHIONINE IN THE PBMCS OF PEOPLE WITH AIDSDEPENDS ON METHOD OF EXPRESSION, Journal of acquired immune deficiency syndromes and human retrovirology, 8(3), 1995, pp. 313-314
Authors:
CUNDY KC
BARDITCHCROVO P
WALKER RE
COLLIER AC
EBELING D
TOOLE J
JAFFE HS
Citation: Kc. Cundy et al., CLINICAL PHARMACOKINETICS OF ADEFOVIR IN HUMAN-IMMUNODEFICIENCY-VIRUSTYPE 1-INFECTED PATIENTS, Antimicrobial agents and chemotherapy, 39(11), 1995, pp. 2401-2405